CytomX Therapeutics, Inc. (CTMX)
3.76
+0.04
(+1.08%)
USD |
NASDAQ |
May 21, 11:53
CytomX Therapeutics EPS Diluted (Quarterly) : -0.1029 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 0.5022 |
| Rigel Pharmaceuticals, Inc. | 0.4396 |
| Ovid Therapeutics, Inc. | -0.1248 |
| Gossamer Bio, Inc. | -0.1993 |
| Mirum Pharmaceuticals, Inc. | -13.43 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -18.25M |
| Revenue (Quarterly) | 10.26M |
| Total Expenses (Quarterly) | 28.51M |
| Enterprise Value | 466.00M |
| Gross Profit Margin (Quarterly) | 97.55% |
| Profit Margin (Quarterly) | -177.9% |
| Earnings Yield | -9.67% |
| Normalized Earnings Yield | -9.686 |